Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 14.54
+0.74 (5.36%)
May 29, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Neuren Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $23.45. The average 1-year stock price forecast is 61.28% higher than the current stock price, while the lowest is $18.60 (+27.92%) and the highest is $29.00 (+99.45%).
Price Target: $23.45 (+61.28%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Neuren Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $24.00 | Buy | Maintains | $24.00 | +65.06% | May 19, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $22.00 | Buy | Maintains | $22.00 | +51.31% | May 9, 2026 |
| Macquarie | Macquarie | Buy Maintains $19.10 | Buy | Maintains | $19.10 | +31.36% | Mar 3, 2026 |
| Jefferies | Jefferies | Buy Maintains $27.00 | Buy | Maintains | $27.00 | +85.69% | Feb 6, 2026 |
| Petra Capital | Petra Capital | Buy Maintains $29.96 | Buy | Maintains | $29.96 | +106.05% | Feb 5, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.